Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 925,070 | 839,958 | 1,339,322 | 1,319,486 |
| Cost of Goods | 545,070 | 461,435 | 647,971 | 588,593 |
| Gross Profit | 380,000 | 378,520 | 691,350 | 657,210 |
| Operating Expenses | 411,647 | 375,752 | 540,336 | 411,602 |
| Operating Income | -31,577 | 3,206 | 151,986 | 319,884 |
| Interest Expense | 909 | 1,020 | 1,146 | 2,425 |
| Other Income | 17,166 | 20,734 | 58,537 | 32,705 |
| Pre-tax Income | -15,320 | 22,920 | 209,377 | 350,164 |
| Income Tax | -10,286 | 0 | 64,907 | 110,996 |
| Net Income Continuous | -5,034 | 22,920 | 144,470 | 239,168 |
| Net Income Discontinuous | -62,780 | 0 | 0 | -89,788 |
| Net Income | $-67,814 | $22,920 | $144,470 | $149,380 |
| EBITDA(a) | $41,313 | $49,136 | $203,916 | $360,024 |